DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Apixaban
Apixaban
Interindividual Variability of Apixaban Plasma Concentrations: Influence of Clinical and Genetic Factors in a Real-Life Cohort O
Clinical Protocol
STUDY PROTOCOL Study Information Title Apixaban Drug
Standard-Dose Apixaban After Very Low-Dose Thrombolysis for Acute Intermediate-High Risk Acute Pulmonary Embolism
New Age of Anticoagulants
Edoxaban Switch Programme - Frequently Asked Questions
SIGN 129 • Antithrombotics: Indications and Management
Emergency Management of Patients on Direct Oral Anticoagulants (Doacs)
Apixaban (Eliquis®) What You Need to Know
Presentazione Standard Di Powerpoint
Anticoagulation Guidelines for COVID 19 Patients Riverside Health System
Therapeutic Class Overview Oral Anticoagulants
Elective Surgery and Invasive Procedures in Patients Taking
The Pharmacodynamic Effect of ELIQUIS Can Be Expected to Persist for at Least 24 Hours After the Last Dose, Ie, for About Two Drug Half Lives
Apixaban and Rosuvasłłtatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease
Low Dosis of Alteplase, for Ischemic Stroke After Enchanted and Its Determinants, a Single Center Experience
Study Protocol
Combining Antiplatelets and Anticoagulants Example
Top View
NON-INTERVENTIONAL (NI) STUDY PROTOCOL Post
COVID-19 Vaccine Astrazeneca (Other Viral Vaccines) EPITT No:19683
Inclusions and Exclusions for IV
Eliquis (Apixaban)
Eliquis 2.5 Mg Film-Coated Tablets
Managing New Oral Anticoagulants in the Perioperative and Intensive
Treatment with Apixaban | Eliquis |
ELIQUIS Product Monograph
Switching from Warfarin to ELIQUIS® (Apixaban) Patient Information Booklet
Guidance on Safe Switching of Warfarin to DOAC
Prescriptions of Direct Oral Anticoagulants in Patients Admitted
Quantification of Apixaban in Human Plasma Using Ultra Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry
Rivaroxaban and Apixaban for DVTVTE Prophylaxis
Apixaban) Tablets
Anti-Platelet and Anti-Coagulant Prescriptions and Breast Cancer Recurrence: a Danish Nationwide Prospective Cohort Study
Comparison of New Anticoagulants to Warfarin and Low-Molecular-Weight Heparin
ELIQUIS Safely and Effectively
Which Direct Oral Anticoagulant (DOAC) Is Best for My Patient?
Apixaban As a Therapeutic Option in Chronic Kidney Disease Patients with Heparin-Induced Thrombocytopenia (HIT)
What Is Apixaban (Eliquis)?
ELIQUIS Safely • the Recommended Dose Is 2.5 Mg Orally Twice Daily
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Management of Dental Patients Taking Anticoagulants Or Antiplatelets
Apixaban Core Slide Deck for Reactive
Oral Direct Thrombin Inhibitors Or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism (Review)
Acute Coronary Syndrome [G] Combination Therapy
Direct-Acting Oral Anticoagulant Use at Extremes of Body Weight
Oral Anticoagulants: Considerations for Use of Warfarin, Apixaban and Rivaroxaban
Effectiveness and Safety of Apixaban Vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
Apixaban Triumphs Over Aspirin for Stroke Prevention in Patients with Atrial Fibrillation
Objectives the Evolution of Anticoagulant Drugs
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
Switching to and from Various Anticoagulants
Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation ROBERT A
Measuring Concentrations of Rivaroxaban, Apixaban, Edoxaban
SPAF-3 Slideset #4
New Oral Anticoagulants in the ED Setting: a Review Charles V
Direct Oral Anticoagulants (Doacs) Guide
Enoxaparin – Prescribing, Administration and Monitoring
ELIQUIS Safely and Effectively
Direct Oral Anticoagulants (Doacs)
Apixaban Eliquis 1
Apixaban and Rosuvastatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease
Venous Thromboembolism : Evolution of Anticoagulation Therapy
Rivaroxaban (Xarelto), and Apixaban (Eliquis) September 2013 VHA Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives
Antiplatelets and Anticoagulation in Stroke – Quick Reference Guide Clinical Guideline
Apixaban Monograph
Medicines for Stroke Prevention in Atrial Fibrillation Choosing the Right One for You
Apixaban (Eliquis) National Drug Monograph May 2013 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives